Clinical Trial Purpose
The PROGRESS IV clinical trial will evaluate the safety and clinical effectiveness of autologous protein solution (APS), prepared from a small sample of a patient’s own blood with an investigational device called the nSTRIDE® APS Kit, on pain and function associated with knee osteoarthritis (OA).